Tim-3 expression and its role in hepatocellular carcinoma

被引：107
|
作者：
Liu, Feifei [1 ]
Liu, Yanning [1 ]
Chen, Zhi [1 ]
机构：
[1] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Coll Med,Collaborat Innovat Ctr Diag & Treatment, 79 Qingchun Rd,6A-17, Hangzhou 310003, Zhejiang, Peoples R China
来源：
JOURNAL OF HEMATOLOGY & ONCOLOGY | 2018年 / 11卷
关键词：
Hepatocellular carcinoma; Tim-3; Immune checkpoint blockade; Immunotherapy; T-CELL IMMUNOGLOBULIN; EPITHELIAL-MESENCHYMAL TRANSITION; OLIGONUCLEOTIDE APTAMER; ANTITUMOR IMMUNITY; PD-1; BLOCKADE; UP-REGULATION; CANCER; RECEPTOR; THERAPY; MUCIN-3;
D O I：
10.1186/s13045-018-0667-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatocellular carcinoma (HCC) is one of the most common tumors in the world, and its mortality is still on the rise. Limited treatments and low chemotherapy sensitivity of HCC make new therapeutic strategies urgently needed. With the rise of immune checkpoint blockade, anti-CTLA-4 antibodies and anti-PD-1 antibodies have shown therapeutic effects in various tumors. T cell immunoglobulin mucin-3 (Tim-3), a newly discovered immune checkpoint molecule, plays a major role in the development of HCC. Tim-3 can be used to evaluate the prognosis and therapeutic effects in HCC, and Tim-3 intervention has shown anti-tumor effects in preclinical experiments. This review summarizes findings regarding Tim-3 and HCC in recent years and discusses the rationale of Tim-3 as a therapeutic target for HCC.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
    Xingming Zhang
    Xiaoxue Yin
    Haoran Zhang
    Guangxi Sun
    Yaojing Yang
    Junru Chen
    Kunpeng Shu
    Jinge Zhao
    Peng Zhao
    Ni Chen
    Jia Wang
    Pengfei Shen
    Hao Zeng
    BMC Cancer, 19
  • [22] Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
    Zhang, Xingming
    Yin, Xiaoxue
    Zhang, Haoran
    Sun, Guangxi
    Yang, Yaojing
    Chen, Junru
    Shu, Kunpeng
    Zhao, Jinge
    Zhao, Peng
    Chen, Ni
    Wang, Jia
    Shen, Pengfei
    Zeng, Hao
    BMC CANCER, 2019, 19 (1)
  • [23] Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection
    Huang, Bo
    Liu, Man
    Huang, Shiguang
    Wu, Bin
    Guo, Hong
    Su, Xin-zhuan
    Lu, Fangli
    PARASITOLOGY RESEARCH, 2013, 112 (07) : 2713 - 2719
  • [24] TIM-3 Expression on Dendritic Cells in Colorectal Cancer
    Sakuma, Mei
    Katagata, Masanori
    Okayama, Hirokazu
    Nakajima, Shotaro
    Saito, Katsuharu
    Sato, Takahiro
    Fukai, Satoshi
    Tsumuraya, Hideaki
    Onozawa, Hisashi
    Sakamoto, Wataru
    Saito, Motonobu
    Saze, Zenichiro
    Momma, Tomoyuki
    Mimura, Kosaku
    Kono, Koji
    CANCERS, 2024, 16 (10)
  • [25] Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection
    Bo Huang
    Man Liu
    Shiguang Huang
    Bin Wu
    Hong Guo
    Xin-zhuan Su
    Fangli Lu
    Parasitology Research, 2013, 112 : 2713 - 2719
  • [26] The Expression of Tim-3 in Peripheral Blood of Ovarian Cancer
    Wu, Jie
    Liu, Cuiying
    Qian, Shao
    Hou, Hongchun
    DNA AND CELL BIOLOGY, 2013, 32 (11) : 648 - 653
  • [27] TIM-3 expression and markers of immune escape on leukemia
    Kuzelova, K.
    Brodska, B.
    Otevrelova, P.
    Salek, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1463 - S1463
  • [28] TIM-3 in autoimmunity
    Anderson, Ana C.
    Anderson, David E.
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) : 665 - 669
  • [29] DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells
    F-C Chou
    C-C Kuo
    H-Y Chen
    H-H Chen
    H-K Sytwu
    Genes & Immunity, 2016, 17 : 179 - 186
  • [30] DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells
    Chou, F-C
    Kuo, C-C
    Chen, H-Y
    Chen, H-H
    Sytwu, H-K
    GENES AND IMMUNITY, 2016, 17 (03) : 179 - 186
12345